Oropharyax cancer (OPC) in TAX 324: Human papillomavirus (HPV) and survival

被引：5
|
作者：
Posner, M. R.
Lorch, J. H.
Goloubeva, O.
Tan, M.
Schumaker, L.
Sartis, N. J.
Haddad, R. I.
Cullen, K. J.
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Univ Maryland, Marlene & Stewart Greertebaum Canc Ctr, Baltimore, MD 21201 USA
[3] Sanofi Eventis US, Bridgewater, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5525
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5525
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FIVE-YEAR SURVIVAL (OS) AND PATTERNS OF FAILURE FOR HUMAN PAPILLOMAVIRUS (HPV) POSITIVE AND NEGATIVE OROPHARYNX CANCER (OPC) IN THE TAX 324 CLINICAL TRIAL: RESULTS OF SEQUENTIAL THERAPY
    Posner, M.
    Lorch, J.
    Goloubeva, O.
    Tan, M.
    Schumaker, L.
    Sarlis, N.
    Haddad, R.
    Cullen, K. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 314 - 314
  • [2] Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
    Posner, M. R.
    Lorch, J. H.
    Goloubeva, O.
    Tan, M.
    Schumaker, L. M.
    Sarlis, N. J.
    Haddad, R. I.
    Cullen, K. J.
    ANNALS OF ONCOLOGY, 2011, 22 (05) : 1071 - 1077
  • [3] Retropharyngeal Lymph Node Involvement in Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer (OPC)
    Lin, T.
    Elhalawani, H.
    Elgohari, B.
    Debnam, M.
    Jethanandani, A.
    Ng, S. P.
    Mohamed, A. S.
    Frank, S. J.
    Sturgis, E. M.
    Phan, J.
    Reddy, J.
    Fuller, C. D.
    Morrison, W. H.
    Skinner, H. D.
    Rosenthal, D. I.
    Garden, A. S.
    Gunn, G. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S198 - S199
  • [4] Human Papillomavirus-Associated Oropharynx Cancer (HPV-OPC): Treatment Options
    Nicole G. Chau
    Guilherme Rabinowits
    Robert I. Haddad
    Current Treatment Options in Oncology, 2014, 15 : 595 - 610
  • [5] Human Papillomavirus-Associated Oropharynx Cancer (HPV-OPC): Treatment Options
    Chau, Nicole G.
    Rabinowits, Guilherme
    Haddad, Robert I.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 595 - 610
  • [6] Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129
    Gillison, M. L.
    Harris, J.
    Westra, W.
    Chung, C.
    Jordan, R.
    Rosenthal, D.
    Nguyen-Tan, P.
    Spanos, W. J.
    Redmond, K. P.
    Ang, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] The Rise of Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer (OPC) in Toronto, Canada: A Case for Vaccinating Males
    Habbous, Steven
    Chu, Karen P.
    La Delfa, Anthony
    Harland, Luke
    Qiu, Xin
    Xu, Wei
    Goldstein, David P.
    Waldron, John
    O'Sullivan, Brian
    Huang, Shao-Hui
    Liu, Geoffrey
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 7 - 8
  • [8] Risk Factors Predictive for Poor Outcomes in Patients With Human Papillomavirus (HPV)-Initiated Oropharyngeal Cancer (OPC)
    Nwizu, T.
    Koyfman, S.
    Bledsoe, T. B.
    Hyslop, E.
    Reddy, C. A.
    Lamarre, E.
    Scharpf, J.
    Burkey, B. B.
    Greskovich, J. F.
    Adelstein, D. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 473 - 473
  • [9] Risk factors predictive for poor outcomes in patients with human papillomavirus (HPV)-initiated oropharyngeal cancer (OPC)
    Nwizu, Tobenna Igweonu
    Koyfman, Shlomo A.
    Bledsoe, Trevor B.
    Hyslop, Emily
    Reddy, Chandana A.
    Lamarre, Eric
    Scharpf, Joseph
    Lorenz, Robert
    Khan, Mumtaz
    Burkey, Brian
    Greskovich, John
    Adelstein, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Discourse about human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) on Twitter: Lessons for public health education about OPC and dental care
    Chung, Jae Eun
    Mustapha, Indra Z.
    Li, Jiang
    Gu, Xinbin
    PUBLIC HEALTH IN PRACTICE, 2022, 3
12345